{"title":"Sjögren综合征患者的口腔康复","authors":"Balić Merima, Ovari Zoltan","doi":"10.17352/2455-4634.000054","DOIUrl":null,"url":null,"abstract":"Sjögren syndrome (SS) is a chronic autoimmune disease characterized by inflammation of salivary and lacrymal glands, causing oral and ocular dryness [1]. The syndrome was named by Swedish ophthalmologist Henrik Sjögren, who identified it in 1933. SS prevalence ranges between 0. 5 % and 3 % and the syndrome is more likely to affect females over 40 years old, especially in menopause [2, 3]. It is a slowly progressing, non-life-threatening disease with a 10-year cumulative survival rate of over 90 % [4].","PeriodicalId":144574,"journal":{"name":"International Journal of Oral and Craniofacial Science","volume":"189 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-08-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Oral rehabilitation of a patient with Sjögren syndrome\",\"authors\":\"Balić Merima, Ovari Zoltan\",\"doi\":\"10.17352/2455-4634.000054\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Sjögren syndrome (SS) is a chronic autoimmune disease characterized by inflammation of salivary and lacrymal glands, causing oral and ocular dryness [1]. The syndrome was named by Swedish ophthalmologist Henrik Sjögren, who identified it in 1933. SS prevalence ranges between 0. 5 % and 3 % and the syndrome is more likely to affect females over 40 years old, especially in menopause [2, 3]. It is a slowly progressing, non-life-threatening disease with a 10-year cumulative survival rate of over 90 % [4].\",\"PeriodicalId\":144574,\"journal\":{\"name\":\"International Journal of Oral and Craniofacial Science\",\"volume\":\"189 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-08-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Oral and Craniofacial Science\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.17352/2455-4634.000054\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Oral and Craniofacial Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17352/2455-4634.000054","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Oral rehabilitation of a patient with Sjögren syndrome
Sjögren syndrome (SS) is a chronic autoimmune disease characterized by inflammation of salivary and lacrymal glands, causing oral and ocular dryness [1]. The syndrome was named by Swedish ophthalmologist Henrik Sjögren, who identified it in 1933. SS prevalence ranges between 0. 5 % and 3 % and the syndrome is more likely to affect females over 40 years old, especially in menopause [2, 3]. It is a slowly progressing, non-life-threatening disease with a 10-year cumulative survival rate of over 90 % [4].
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
